Aducanumab for the treatment of Alzheimer's disease: a systematic review

Rahman, Afroza; Anwar Hossen, Md; Farhana Iqbal Chowdhury, Mirza; Bari, Sadia; Tamanna, Nuzhat; Salima Sultana, Syeda; Naiarin Haque, Sharar; Al Masud, Abdullah; Saif‐Ur‐Rahman, K.M.

doi:10.1111/psyg.12944

Public

Aducanumab for the treatment of Alzheimer's disease: a systematic review

Shared by NobleBlocks on Feb 12, 2023 • 12:00 AM UTC

Authors:

Afroza Rahman

Md Anwar Hossen

Mirza Farhana Iqbal Chowdhury

Abstract

Aducanumab is a novel disease‐modifying anti‐amyloid‐beta (Aβ) human monoclonal antibody specifically targeted to the pathophysiology of Alzheimer's disease (AD). It was granted for treating AD in June 2021 by the United States Food and Drug Administration. We systematically analyzed available trial...

Discussions